![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 28, 13983-13986, Oct, 1988
PR Dobner, AS Tischler, YC Lee, SR Bloom and SR Donahue
Lithium perturbs intracellular signal transduction pathways used by
neurotransmitters, suggesting that changes in receptor signalling may
underlie its actions in the treatment of manic depressive illness. Little
attention, however, has been directed toward possible additional actions at
the level of specific gene expression, particularly of genes encoding
neurotransmitters or neuromodulators. In PC12 pheochromocytoma cells,
lithium dramatically potentiates increases in intracellular levels of the
neuropeptide neurotensin and the mRNA encoding it, caused by combinations
of nerve growth factor, dexamethasone, and the adenylate cyclase activator,
forskolin. This result demonstrates that lithium can profoundly influence
the expression of a specific neuropeptide gene in a previously
unanticipated manner and suggests that changes in gene expression might be
involved in its therapeutic activity.
Lithium dramatically potentiates neurotensin/neuromedin N gene expression
Department of Molecular Genetics and Microbiology, University of Massachusetts Medical Center, Worcester 01655.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Rovère, P. Barbero, and P. Kitabgi Evidence That PC2 Is the Endogenous Pro-neurotensin Convertase in rMTC 6-23 Cells and That PC1- and PC2-transfected PC12 Cells Differentially Process Pro-neurotensin J. Biol. Chem., May 10, 1996; 271(19): 11368 - 11375. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Xing, C. Johnson, P. Dobner, and J. Lawrence Higher level organization of individual gene transcription and RNA splicing Science, February 26, 1993; 259(5099): 1326 - 1330. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |